Healthpeak Properties (NYSE:DOC) Downgraded to Sell Rating by Wall Street Zen

Healthpeak Properties (NYSE:DOC) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Several other brokerages have also commented on DOC. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and lowered their price target for the company from $21.00 to $17.00 in a research report on Monday, December 15th. Cantor Fitzgerald set a $17.00 price objective on shares of Healthpeak Properties in a research note on Monday, January 5th. Weiss Ratings raised shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Finally, The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They set a “neutral” rating and a $17.00 target price for the company. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $19.42.

Healthpeak Properties Stock Down 1.5%

Shares of NYSE:DOC opened at $16.54 on Friday. The firm has a market capitalization of $11.50 billion, a P/E ratio of 165.45, a P/E/G ratio of 8.99 and a beta of 1.12. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The stock has a 50 day moving average price of $17.21 and a 200-day moving average price of $17.51. Healthpeak Properties has a 52-week low of $15.71 and a 52-week high of $20.40.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.02. The company had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm’s revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts anticipate that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Institutional Investors Weigh In On Healthpeak Properties

Several institutional investors and hedge funds have recently made changes to their positions in DOC. Purpose Unlimited Inc. bought a new position in Healthpeak Properties in the 4th quarter valued at approximately $451,000. Hsbc Holdings PLC increased its holdings in shares of Healthpeak Properties by 7.1% in the 4th quarter. Hsbc Holdings PLC now owns 3,262,602 shares of the real estate investment trust’s stock worth $52,462,000 after purchasing an additional 217,394 shares in the last quarter. Rockefeller Capital Management L.P. raised its stake in shares of Healthpeak Properties by 1.7% in the fourth quarter. Rockefeller Capital Management L.P. now owns 185,118 shares of the real estate investment trust’s stock worth $2,977,000 after purchasing an additional 3,025 shares during the last quarter. Advisortrust Partners LLC purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $388,000. Finally, Corient Private Wealth LLC lifted its holdings in shares of Healthpeak Properties by 3.5% during the fourth quarter. Corient Private Wealth LLC now owns 70,256 shares of the real estate investment trust’s stock valued at $1,130,000 after purchasing an additional 2,376 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.